Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $INDV vs $LGND | Chartloom

Compare

$INDV vs $LGND

Indivior Pharmaceuticals, Inc · Ligand Pharmaceuticals Inc

INDV

Indivior Pharmaceuticals, Inc

LGND

Ligand Pharmaceuticals Inc

Compare $INDV vs $LGND

Comparing Indivior Pharmaceuticals, Inc and Ligand Pharmaceuticals Inc

INDVIndivior Pharmaceuticals, Inc

LGNDLigand Pharmaceuticals Inc

INDVIndivior Pharmaceuticals, Inc

Market cap

$4.29B

P/E (TTM)

12.37x

Forward P/E (NTM)

7.50x

Forward P/S (NTM)

3.13x

Rev growth (TTM)

13.6%

YTD performance

-0.9%

52W performance

48.9%

FCF yield

-2.5%

LGNDLigand Pharmaceuticals Inc

Market cap

$6.08B

P/E (TTM)

33.61x

Forward P/E (NTM)

28.81x

Forward P/S (NTM)

17.73x

Rev growth (TTM)

54.9%

YTD performance

59.7%

52W performance

70.8%

FCF yield

2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INDV

LGND

Detailed metrics comparison

INDV

Indivior Pharmaceuticals, Inc

LGND

Ligand Pharmaceuticals Inc

Market Cap

INDV$4.29B

LGND$6.08B

Enterprise Value

INDV$4.55B

LGND$6.20B

Price

INDV$35.42

LGND$303.53

P/E Ratio

INDV12.37x

LGND33.61x

P/S Ratio

INDV3.22x

LGND20.94x

EV/Sales

INDV3.42x

LGND21.35x

EV/EBITDA

INDV10.26x

LGND42.81x

P/B Ratio

INDV422.91x

LGND6.22x

P/FCF Ratio

INDVN/A

LGND45.31x

EV/FCF

INDV-41.75x

LGND46.20x

PEG Ratio

INDV0.41x

LGND1.33x

Forward P/E (NTM)

INDV7.50x

LGND28.81x

Forward P/S (NTM)

INDV3.13x

LGND17.73x

Revenue (TTM)

INDV$1.33B

LGND$291M

Revenue Growth (YoY)

INDV13.6%

LGND54.9%

Forward Rev Growth

INDV5.4%

LGND31.3%

Gross Margin (TTM)

INDV82.0%

LGND95.4%

Operating Margin (TTM)

INDV30.3%

LGND32.6%

EBITDA Margin (TTM)

INDV33.1%

LGND45.8%

Net Margin (TTM)

INDV26.7%

LGND67.9%

FCF Margin (TTM)

INDV-8.2%

LGND46.2%

Net Income (TTM)

INDV$355M

LGND$197M

FCF (TTM)

INDV$-109M

LGND$134M

EPS (TTM)

INDV$2.86

LGND$9.03

ROE (TTM)

INDV159.1%

LGND20.1%

ROA (TTM)

INDV28.1%

LGND11.7%

ROIC (TTM)

INDV29.4%

LGND12.3%

Cash

INDV$222M

LGND$1.01B

Debt

INDV$487M

LGND$1.13B

Net Cash/Debt

INDV$-265M

LGND$-120M

Current Ratio (TTM)

INDV0.84x

LGND31.18x

Quick Ratio (TTM)

INDV0.65x

LGND30.96x

Debt/Equity (TTM)

INDV27.90x

LGND1.16x

Debt/Assets (TTM)

INDV0.0%

LGND0.0%

Interest Coverage (TTM)

INDVN/A

LGNDN/A

Net Debt/EBITDA (TTM)

INDV0.00x

LGND0.00x

Beta

INDV0.49

LGND1.23

52W Performance

INDV48.9%

LGND70.8%

YTD Performance

INDV-0.9%

LGND59.7%

% from 52W High

INDV-17.3%

LGND-7.1%

% from 52W Low

INDV50.4%

LGND72.6%

Asset Turnover (TTM)

INDV1.06x

LGND0.17x

FCF Yield (TTM)

INDV-2.5%

LGND2.2%

Earnings Yield (TTM)

INDV8.3%

LGND3.2%

Dividend Yield (TTM)

INDVN/A

LGNDN/A

Rule of 40

INDV5.4

LGND101.1

EV/GP/RG

INDV1.40

LGND1.14

Ticker research

View INDV research View LGND research

Metric	INDV Indivior Pharmaceuticals, Inc	LGND Ligand Pharmaceuticals Inc
Market & Valuation
Market Cap	$4.29B	$6.08B
Enterprise Value	$4.55B	$6.20B
Price	$35.42	$303.53
P/E Ratio	12.37x	33.61x
P/S Ratio	3.22x	20.94x
EV/Sales	3.42x	21.35x
EV/EBITDA	10.26x	42.81x
P/B Ratio	422.91x	6.22x
P/FCF Ratio	N/A	45.31x
EV/FCF	-41.75x	46.20x
PEG Ratio	0.41x	1.33x
Forward P/E (NTM)	7.50x	28.81x
Forward P/S (NTM)	3.13x	17.73x
Revenue & Growth
Revenue (TTM)	$1.33B	$291M
Revenue Growth (YoY)	13.6%	54.9%
Forward Rev Growth	5.4%	31.3%
Profitability
Gross Margin (TTM)	82.0%	95.4%
Operating Margin (TTM)	30.3%	32.6%
EBITDA Margin (TTM)	33.1%	45.8%
Net Margin (TTM)	26.7%	67.9%
FCF Margin (TTM)	-8.2%	46.2%
Net Income (TTM)	$355M	$197M
FCF (TTM)	$-109M	$134M
EPS (TTM)	$2.86	$9.03
ROE (TTM)	159.1%	20.1%
ROA (TTM)	28.1%	11.7%
ROIC (TTM)	29.4%	12.3%
Financial Health
Cash	$222M	$1.01B
Debt	$487M	$1.13B
Net Cash/Debt	$-265M	$-120M
Current Ratio (TTM)	0.84x	31.18x
Quick Ratio (TTM)	0.65x	30.96x
Debt/Equity (TTM)	27.90x	1.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.23
52W Performance	48.9%	70.8%
YTD Performance	-0.9%	59.7%
% from 52W High	-17.3%	-7.1%
% from 52W Low	50.4%	72.6%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.17x
FCF Yield (TTM)	-2.5%	2.2%
Earnings Yield (TTM)	8.3%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	101.1
EV/GP/RG	1.40	1.14
Ticker research	View INDV research	View LGND research

Valuation

P/E Ratio

INDV

12.37x

LGND

33.61x

P/S Ratio

INDV

3.22x

LGND

20.94x

EV/FCF

INDV

-41.75x

LGND

46.20x

Growth & revenue

Revenue Growth TTM

LGND

54.9%

INDV

13.6%

Forward Revenue Growth

LGND

31.3%

INDV

5.4%

Profitability & performance

Gross Margin

LGND

95.4%

INDV

82.0%

ROE

INDV

159.1%

LGND

20.1%

FCF Yield %

LGND

2.2%

INDV

-2.5%

52-Week Performance

LGND

70.8%

INDV

48.9%

Detailed metrics comparison

INDV

Indivior Pharmaceuticals, Inc

LGND

Ligand Pharmaceuticals Inc

Market Cap

INDV$4.29B

LGND$6.08B

Enterprise Value

INDV$4.55B

LGND$6.20B

Price

INDV$35.42

LGND$303.53

P/E Ratio

INDV12.37x

LGND33.61x

P/S Ratio

INDV3.22x

LGND20.94x

EV/Sales

INDV3.42x

LGND21.35x

EV/EBITDA

INDV10.26x

LGND42.81x

P/B Ratio

INDV422.91x

LGND6.22x

P/FCF Ratio

INDVN/A

LGND45.31x

EV/FCF

INDV-41.75x

LGND46.20x

PEG Ratio

INDV0.41x

LGND1.33x

Forward P/E (NTM)

INDV7.50x

LGND28.81x

Forward P/S (NTM)

INDV3.13x

LGND17.73x

Revenue (TTM)

INDV$1.33B

LGND$291M

Revenue Growth (YoY)

INDV13.6%

LGND54.9%

Forward Rev Growth

INDV5.4%

LGND31.3%

Gross Margin (TTM)

INDV82.0%

LGND95.4%

Operating Margin (TTM)

INDV30.3%

LGND32.6%

EBITDA Margin (TTM)

INDV33.1%

LGND45.8%

Net Margin (TTM)

INDV26.7%

LGND67.9%

FCF Margin (TTM)

INDV-8.2%

LGND46.2%

Net Income (TTM)

INDV$355M

LGND$197M

FCF (TTM)

INDV$-109M

LGND$134M

EPS (TTM)

INDV$2.86

LGND$9.03

ROE (TTM)

INDV159.1%

LGND20.1%

ROA (TTM)

INDV28.1%

LGND11.7%

ROIC (TTM)

INDV29.4%

LGND12.3%

Cash

INDV$222M

LGND$1.01B

Debt

INDV$487M

LGND$1.13B

Net Cash/Debt

INDV$-265M

LGND$-120M

Current Ratio (TTM)

INDV0.84x

LGND31.18x

Quick Ratio (TTM)

INDV0.65x

LGND30.96x

Debt/Equity (TTM)

INDV27.90x

LGND1.16x

Debt/Assets (TTM)

INDV0.0%

LGND0.0%

Interest Coverage (TTM)

INDVN/A

LGNDN/A

Net Debt/EBITDA (TTM)

INDV0.00x

LGND0.00x

Beta

INDV0.49

LGND1.23

52W Performance

INDV48.9%

LGND70.8%

YTD Performance

INDV-0.9%

LGND59.7%

% from 52W High

INDV-17.3%

LGND-7.1%

% from 52W Low

INDV50.4%

LGND72.6%

Asset Turnover (TTM)

INDV1.06x

LGND0.17x

FCF Yield (TTM)

INDV-2.5%

LGND2.2%

Earnings Yield (TTM)

INDV8.3%

LGND3.2%

Dividend Yield (TTM)

INDVN/A

LGNDN/A

Rule of 40

INDV5.4

LGND101.1

EV/GP/RG

INDV1.40

LGND1.14

Ticker research

View INDV research View LGND research

Metric	INDV Indivior Pharmaceuticals, Inc	LGND Ligand Pharmaceuticals Inc
Market & Valuation
Market Cap	$4.29B	$6.08B
Enterprise Value	$4.55B	$6.20B
Price	$35.42	$303.53
P/E Ratio	12.37x	33.61x
P/S Ratio	3.22x	20.94x
EV/Sales	3.42x	21.35x
EV/EBITDA	10.26x	42.81x
P/B Ratio	422.91x	6.22x
P/FCF Ratio	N/A	45.31x
EV/FCF	-41.75x	46.20x
PEG Ratio	0.41x	1.33x
Forward P/E (NTM)	7.50x	28.81x
Forward P/S (NTM)	3.13x	17.73x
Revenue & Growth
Revenue (TTM)	$1.33B	$291M
Revenue Growth (YoY)	13.6%	54.9%
Forward Rev Growth	5.4%	31.3%
Profitability
Gross Margin (TTM)	82.0%	95.4%
Operating Margin (TTM)	30.3%	32.6%
EBITDA Margin (TTM)	33.1%	45.8%
Net Margin (TTM)	26.7%	67.9%
FCF Margin (TTM)	-8.2%	46.2%
Net Income (TTM)	$355M	$197M
FCF (TTM)	$-109M	$134M
EPS (TTM)	$2.86	$9.03
ROE (TTM)	159.1%	20.1%
ROA (TTM)	28.1%	11.7%
ROIC (TTM)	29.4%	12.3%
Financial Health
Cash	$222M	$1.01B
Debt	$487M	$1.13B
Net Cash/Debt	$-265M	$-120M
Current Ratio (TTM)	0.84x	31.18x
Quick Ratio (TTM)	0.65x	30.96x
Debt/Equity (TTM)	27.90x	1.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.23
52W Performance	48.9%	70.8%
YTD Performance	-0.9%	59.7%
% from 52W High	-17.3%	-7.1%
% from 52W Low	50.4%	72.6%
Efficiency & Yields
Asset Turnover (TTM)	1.06x	0.17x
FCF Yield (TTM)	-2.5%	2.2%
Earnings Yield (TTM)	8.3%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.4	101.1
EV/GP/RG	1.40	1.14
Ticker research	View INDV research	View LGND research